{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T18:02:52Z","timestamp":1794852172294,"version":"4.9.1"},"reference-count":206,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,10,27]],"date-time":"2023-10-27T00:00:00Z","timestamp":1698364800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,10,27]],"date-time":"2023-10-27T00:00:00Z","timestamp":1698364800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["RC2023"],"award-info":[{"award-number":["RC2023"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Biomed Sci"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The NLRP3 inflammasome is an intracellular sensor and an essential component of the innate immune system involved in danger recognition. An important hallmark of inflammasome activation is the formation of a single supramolecular punctum, known as a speck, per cell, which is the site where the pro-inflammatory cytokines IL-1\u03b2 and IL-18 are converted into their bioactive form. Speck also provides the platform for gasdermin D protein activation, whose N-terminus domain perforates the plasma membrane, allowing the release of mature cytokines alongside with a highly inflammatory form of cell death, namely pyroptosis. Although controlled NLRP3 inflammasome-pyroptosis pathway activation preserves mucosal immunity homeostasis and contributes to host defense, a prolonged trigger is deleterious and could lead, in genetically predisposed subjects, to the onset of inflammatory bowel disease, including Crohn's disease and ulcerative colitis, as well as to gastrointestinal cancer. Experimental evidence shows that the NLRP3 inflammasome has both protective and pathogenic abilities. In this review we highlight the impact of the NLRP3-pyroptosis axis on the pathophysiology of the gastrointestinal tract at molecular level, focusing on newly discovered features bearing pro- and anti-inflammatory and neoplastic activity, and on targeted therapies tested in preclinical and clinical trials.<\/jats:p>","DOI":"10.1186\/s12929-023-00983-7","type":"journal-article","created":{"date-parts":[[2023,10,27]],"date-time":"2023-10-27T13:02:57Z","timestamp":1698411777000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["The \u2018speck\u2019-tacular oversight of the NLRP3-pyroptosis pathway on gastrointestinal inflammatory diseases and tumorigenesis"],"prefix":"10.1186","volume":"30","author":[{"given":"Valentina","family":"Arr\u00e8","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosanna","family":"Scialpi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Centonze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianluigi","family":"Giannelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Principia","family":"Scavo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Negro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,10,27]]},"reference":[{"key":"983_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-1-4419-0901-5_1","volume":"653","author":"S Mukhopadhyay","year":"2009","unstructured":"Mukhopadhyay S, Pl\u00fcddemann A, Gordon S. Macrophage pattern recognition receptors in immunity, homeostasis and self tolerance. Adv Exp Med Biol. 2009;653:1\u201314.","journal-title":"Adv Exp Med Biol"},{"issue":"6","key":"983_CR2","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/j.cell.2010.01.022","volume":"140","author":"O Takeuchi","year":"2010","unstructured":"Takeuchi O, Akira S. Pattern recognition receptors and inflammation. Cell. 2010;140(6):805\u201320.","journal-title":"Cell"},{"issue":"5","key":"983_CR3","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1016\/j.cell.2014.04.007","volume":"157","author":"M Lamkanfi","year":"2014","unstructured":"Lamkanfi M, Dixit VM. Mechanisms and functions of inflammasomes. Cell. 2014;157(5):1013\u201322.","journal-title":"Cell"},{"issue":"5","key":"983_CR4","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/j.cell.2011.04.022","volume":"145","author":"E Elinav","year":"2011","unstructured":"Elinav E, Strowig T, Kau AL, Henao-Mejia J, Thaiss CA, Booth CJ, et al. NLRP6 inflammasome regulates colonic microbial ecology and risk for colitis. Cell. 2011;145(5):745\u201357.","journal-title":"Cell"},{"issue":"7","key":"983_CR5","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1038\/nri.2016.58","volume":"16","author":"P Broz","year":"2016","unstructured":"Broz P, Dixit VM. Inflammasomes: mechanism of assembly, regulation and signalling. Nat Rev Immunol. 2016;16(7):407\u201320.","journal-title":"Nat Rev Immunol"},{"issue":"4","key":"983_CR6","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0002119","volume":"3","author":"M Proell","year":"2008","unstructured":"Proell M, Riedl SJ, Fritz JH, Rojas AM, Schwarzenbacher R. The nod-like receptor (NLR) family: a tale of similarities and differences. PLoS ONE. 2008;3(4): e2119.","journal-title":"PLoS ONE"},{"issue":"6510","key":"983_CR7","doi-asserted-by":"publisher","first-page":"eaas8995","DOI":"10.1126\/science.aas8995","volume":"369","author":"VG Magupalli","year":"2020","unstructured":"Magupalli VG, Negro R, Tian Y, Hauenstein AV, Di Caprio G, Skillern W, Deng Q, et al. HDAC6 mediates an aggresome-like mechanism for NLRP3 and pyrin inflammasome activation. Science. 2020;369(6510):eaas8995.","journal-title":"Science"},{"issue":"5","key":"983_CR8","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1038\/s41590-021-00886-5","volume":"22","author":"BR Sharma","year":"2021","unstructured":"Sharma BR, Kanneganti T-D. NLRP3 inflammasome in cancer and metabolic diseases. Nat Immunol. 2021;22(5):550\u20139.","journal-title":"Nat Immunol"},{"key":"983_CR9","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.978190","volume":"13","author":"R Qiang","year":"2022","unstructured":"Qiang R, Li Y, Dai X, Wenliang L. NLRP3 inflammasome in digestive diseases: from mechanism to therapy. Front Immunol. 2022;13: 978190.","journal-title":"Front Immunol"},{"issue":"13","key":"983_CR10","doi-asserted-by":"publisher","first-page":"3328","DOI":"10.3390\/ijms20133328","volume":"20","author":"N Kelley","year":"2020","unstructured":"Kelley N, Jeltema D, Duan Y, He Y. The NLRP3 inflammasome: an overview of mechanisms of activation and regulation. Int J Mol Sci. 2020;20(13):3328.","journal-title":"Int J Mol Sci"},{"key":"983_CR11","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.coi.2020.01.005","volume":"62","author":"L Wang","year":"2020","unstructured":"Wang L, Negro R, Wu H. TRPM2, linking oxidative stress and Ca2+ permeation to NLRP3 inflammasome activation. Curr Opin Immunol. 2020;62:131\u20135.","journal-title":"Curr Opin Immunol"},{"issue":"7","key":"983_CR12","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1038\/s41590-023-01526-w","volume":"24","author":"P Devant","year":"2023","unstructured":"Devant P, Kagan JC. Molecular mechanisms of gasdermin D pore-forming activity. Nat Immunol. 2023;24(7):1064\u201375.","journal-title":"Nat Immunol"},{"issue":"4","key":"983_CR13","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.tibs.2022.10.002","volume":"48","author":"J Xu","year":"2023","unstructured":"Xu J, N\u00fa\u00f1ez G. The NLRP3 inflammasome: activation and regulation. Trends Biochem Sci. 2023;48(4):331\u201344.","journal-title":"Trends Biochem Sci"},{"issue":"7371","key":"983_CR14","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1038\/nature10558","volume":"479","author":"N Kayagaki","year":"2011","unstructured":"Kayagaki N, Warming S, Lamkanfi M, Walle LV, Louie S, Dong J, et al. Non-canonical inflammasome activation targets caspase-11. Nature. 2011;479(7371):117\u201321.","journal-title":"Nature"},{"issue":"4","key":"983_CR15","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1016\/j.immuni.2016.01.012","volume":"44","author":"MM Gaidt","year":"2016","unstructured":"Gaidt MM, Ebert TS, Chauhan D, Schmidt T, Schmid-Burgk JL, Rapino F, et al. Human monocytes engage an alternative inflammasome pathway. Immunity. 2016;44(4):833\u201346.","journal-title":"Immunity"},{"key":"983_CR16","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.1100\/tsw.2011.139","volume":"11","author":"D Lissner","year":"2011","unstructured":"Lissner D, Siegmund B. The multifaceted role of the inflammasome in inflammatory bowel diseases. Sci World J. 2011;11:1536\u20131147.","journal-title":"Sci World J"},{"issue":"3","key":"983_CR17","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/0092-8674(95)90490-5","volume":"80","author":"P Li","year":"1995","unstructured":"Li P, Allen H, Banerjee S, Franklin S, Herzog L, Johnston C, et al. Mice deficient in IL-1 beta-converting enzyme are defective in production of mature IL-1 beta and resistant to endotoxic shock. Cell. 1995;80(3):401\u201311.","journal-title":"Cell"},{"issue":"3","key":"983_CR18","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.immuni.2010.02.012","volume":"32","author":"J Dupaul-Chicoine","year":"2010","unstructured":"Dupaul-Chicoine J, Yeretssian G, Doiron K, Bergstrom KSB, McIntire CR, LeBlanc PM, Meunier C, Turbide C, Gros P, Beauchemin N, et al. Control of intestinal homeostasis, colitis, and colitis-associated colorectal cancer by the inflammatory caspases. Immunity. 2010;32(3):367\u201378.","journal-title":"Immunity"},{"issue":"14","key":"983_CR19","doi-asserted-by":"publisher","first-page":"3033","DOI":"10.1016\/j.cell.2023.05.027","volume":"186","author":"K He","year":"2023","unstructured":"He K, Wan T, Wang D, Hu J, Zhou T, Tao W, et al. Gasdermin D licenses MHCII induction to maintain food tolerance in small intestine. Cell. 2023;186(14):3033-3048.e20.","journal-title":"Cell"},{"issue":"2","key":"983_CR20","doi-asserted-by":"publisher","first-page":"614","DOI":"10.3390\/ijms21020614","volume":"21","author":"HJ Jung","year":"2020","unstructured":"Jung HJ, Kang J-H, Pak S, Lee K, Seong JK, Oh SH. Detrimental role of nerve injury-induced protein 1 in myeloid cells under intestinal inflammatory conditions. Int J Mol Sci. 2020;21(2):614.","journal-title":"Int J Mol Sci"},{"key":"983_CR21","doi-asserted-by":"publisher","first-page":"276","DOI":"10.3389\/fimmu.2019.00276","volume":"10","author":"Y Zhen","year":"2019","unstructured":"Zhen Y, Zhang H. NLRP3 inflammasome and inflammatory bowel disease. Front Immunol. 2019;10:276.","journal-title":"Front Immunol"},{"issue":"7796","key":"983_CR22","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1038\/s41586-020-2025-2","volume":"578","author":"DB Graham","year":"2020","unstructured":"Graham DB, Xavier RJ. Pathway paradigms revealed from the genetics of inflammatory bowel disease. Nature. 2020;578(7796):527\u201339.","journal-title":"Nature"},{"issue":"3","key":"983_CR23","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1172\/JCI30587","volume":"117","author":"W Strober","year":"2007","unstructured":"Strober W, Fuss I, Mannon P. The fundamental basis of inflammatory bowel disease. J Clin Invest. 2007;117(3):514\u201321.","journal-title":"J Clin Invest"},{"issue":"1","key":"983_CR24","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/ng.285","volume":"41","author":"A-C Villani","year":"2009","unstructured":"Villani A-C, Lemire M, Fortin G, Louis E, Silverberg MS, Collette C, et al. Common variants in the NLRP3 region contribute to Crohn\u2019s disease susceptibility. Nat Genet. 2009;41(1):71\u20136.","journal-title":"Nat Genet"},{"issue":"12","key":"983_CR25","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1007\/s00011-014-0774-9","volume":"63","author":"H-X Zhang","year":"2014","unstructured":"Zhang H-X, Wang Z-T, Lu X-X, Wang Y-G, Zhong J, Liu J. NLRP3 gene is associated with ulcerative colitis (UC), but not Crohn\u2019s disease (CD), in Chinese Han population. Inflamm Res. 2014;63(12):979\u201385.","journal-title":"Inflamm Res"},{"issue":"7422","key":"983_CR26","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1038\/nature11582","volume":"491","author":"L Jostins","year":"2012","unstructured":"Jostins L, Ripke S, Weersma RK, Duerr RH, McGovern DP, Hui KY, et al. Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature. 2012;491(7422):119\u201324.","journal-title":"Nature"},{"issue":"1","key":"983_CR27","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.jaci.2020.09.003","volume":"147","author":"T Zhou","year":"2021","unstructured":"Zhou T, Liu B, Huang M, Luo Z, Chen Z, Zhao J, et al. Excessive deubiquitination of NLRP3-R779C variant contributes to very-early-onset inflammatory bowel disease development. J Allergy Clin Immunol. 2021;147(1):267\u201379.","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"983_CR28","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1038\/s41589-019-0278-6","volume":"15","author":"A Tapia-Abell\u00e1n","year":"2019","unstructured":"Tapia-Abell\u00e1n A, Angosto-Bazarra D, Mart\u00ednez-Banaclocha H, de Torre-Minguela C, Cer\u00f3n-Carrasco JP, et al. MCC950 closes the active conformation of NLRP3 to an inactive state. Nat Chem Biol. 2019;15(6):560\u20134.","journal-title":"Nat Chem Biol"},{"key":"983_CR29","doi-asserted-by":"publisher","first-page":"2566","DOI":"10.3389\/fimmu.2018.02566","volume":"9","author":"L Mao","year":"2018","unstructured":"Mao L, Kitani A, Strober W, Fuss IJ. The role of NLRP3 and IL-1\u03b2 in the pathogenesis of inflammatory bowel disease. Front Immunol. 2018;9:2566.","journal-title":"Front Immunol"},{"issue":"1\u20132","key":"983_CR30","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.cell.2017.12.013","volume":"172","author":"A Christ","year":"2018","unstructured":"Christ A, G\u00fcnther P, Lauterbach MAR, Duewell P, Biswas D, Pelka K, et al. Western diet triggers NLRP3-dependent innate immune reprogramming. Cell. 2018;172(1\u20132):162-175.e14.","journal-title":"Cell"},{"key":"983_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2021.111442","volume":"138","author":"Q-L Chen","year":"2021","unstructured":"Chen Q-L, Yin H-R, He Q-Y, Wang Y. Targeting the NLRP3 inflammasome as new therapeutic avenue for inflammatory bowel disease. Biomed Pharmacother. 2021;138: 111442.","journal-title":"Biomed Pharmacother"},{"issue":"3","key":"983_CR32","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1038\/nm.3804","volume":"21","author":"Y-H Youm","year":"2015","unstructured":"Youm Y-H, Nguyen KY, Grant RW, Goldberg EL, Bodogai M, Kim D, et al. The ketone metabolite \u03b2-hydroxybutyrate blocks NLRP3 inflammasome-mediated inflammatory disease. Nat Med. 2015;21(3):263\u20139.","journal-title":"Nat Med"},{"issue":"6","key":"983_CR33","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1016\/j.immuni.2013.05.015","volume":"38","author":"Y Yan","year":"2013","unstructured":"Yan Y, Jiang W, Spinetti T, Tardivel A, Castillo R, Bourquin C. Omega-3 fatty acids prevent inflammation and metabolic disorder through inhibition of NLRP3 inflammasome activation. Immunity. 2013;38(6):1154\u201363.","journal-title":"Immunity"},{"key":"983_CR34","doi-asserted-by":"publisher","first-page":"6734","DOI":"10.1038\/ncomms7734","volume":"6","author":"L Macia","year":"2015","unstructured":"Macia L, Tan J, Vieira AT, Leach K, Stanley D, Luong S, et al. Metabolite-sensing receptors GPR43 and GPR109A facilitate dietary fibre-induced gut homeostasis through regulation of the inflammasome. Nat Commun. 2015;6:6734.","journal-title":"Nat Commun"},{"issue":"5","key":"983_CR35","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1038\/ni.2022","volume":"12","author":"H Wen","year":"2011","unstructured":"Wen H, Gris D, Lei Y, Jha S, Zhang L, Huang MT-H, et al. Fatty acid-induced NLRP3-ASC inflammasome activation interferes with insulin signaling. Nat Immunol. 2011;12(5):408\u201315.","journal-title":"Nat Immunol"},{"key":"983_CR36","doi-asserted-by":"publisher","first-page":"5864","DOI":"10.1038\/ncomms6864","volume":"5","author":"F Progatzky","year":"2015","unstructured":"Progatzky F, Sangha NJ, Yoshida N, McBrien M, Cheung J, Shia A, et al. Dietary cholesterol directly induces acute inflammasome-dependent intestinal inflammation. Nat Commun. 2015;5:5864.","journal-title":"Nat Commun"},{"issue":"1","key":"983_CR37","doi-asserted-by":"publisher","first-page":"91","DOI":"10.3748\/wjg.v20.i1.91","volume":"20","author":"Y-Z Zhang","year":"2014","unstructured":"Zhang Y-Z, Li Y-Y. Inflammatory bowel disease: pathogenesis. World J Gastroenterol. 2014;20(1):91\u20139.","journal-title":"World J Gastroenterol"},{"issue":"1","key":"983_CR38","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/s12967-017-1175-y","volume":"15","author":"RK Singh","year":"2017","unstructured":"Singh RK, Chang H-W, Yan D, Lee KM, Ucmak D, Wong K, et al. Influence of diet on the gut microbiome and implications for human health. J Transl Med. 2017;15(1):73.","journal-title":"J Transl Med"},{"issue":"5","key":"983_CR39","doi-asserted-by":"publisher","first-page":"947","DOI":"10.3390\/nu11050947","volume":"11","author":"N Green","year":"2019","unstructured":"Green N, Miller T, Suskind D, Lee D. A review of dietary therapy for IBD and a vision for the future. Nutrients. 2019;11(5):947.","journal-title":"Nutrients"},{"issue":"3","key":"983_CR40","doi-asserted-by":"publisher","first-page":"126","DOI":"10.3390\/pathogens8030126","volume":"8","author":"I Khan","year":"2019","unstructured":"Khan I, Ullah N, Zha L, Bai Y, Khan A, Zhao T, Che T, Zhang C. Alteration of gut microbiota in inflammatory bowel disease (IBD): cause or consequence? IBD treatment targeting the gut microbiome. Pathogens. 2019;8(3):126.","journal-title":"Pathogens"},{"issue":"2","key":"983_CR41","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/nrgastro.2010.218","volume":"8","author":"B De Vroey","year":"2011","unstructured":"De Vroey B, Colombel J-F. IBD in 2010: optimizing treatment and minimizing adverse events. Nat Rev Gastroenterol Hepatol. 2011;8(2):74\u20136.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"12","key":"983_CR42","first-page":"956","volume":"38","author":"G Morrison","year":"2009","unstructured":"Morrison G, Headon B, Gibson P. Update in inflammatory bowel disease. Aust Fam Phys. 2009;38(12):956\u201361.","journal-title":"Aust Fam Phys"},{"issue":"5","key":"983_CR43","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1093\/ibd\/izy327","volume":"25","author":"KO Chudy-Onwugaje","year":"2019","unstructured":"Chudy-Onwugaje KO, Christian KE, Farraye FA, Cross RK. A state-of-the-art review of new and emerging therapies for the treatment of IBD. Inflamm Bowel Dis. 2019;25(5):820\u201330.","journal-title":"Inflamm Bowel Dis"},{"issue":"6","key":"983_CR44","doi-asserted-by":"publisher","first-page":"604","DOI":"10.5009\/gnl19019","volume":"13","author":"S-Y Na","year":"2019","unstructured":"Na S-Y, Moon W. Perspectives on current and novel treatments for inflammatory bowel disease. Gut Liver. 2019;13(6):604\u201316.","journal-title":"Gut Liver"},{"issue":"10","key":"983_CR45","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.4252\/wjsc.v12.i10.1050","volume":"12","author":"R Mishra","year":"2020","unstructured":"Mishra R, Dhawan P, Srivastava AS, Singh AB. Inflammatory bowel disease: therapeutic limitations and prospective of the stem cell therapy. World J Stem Cells. 2020;12(10):1050\u201366.","journal-title":"World J Stem Cells"},{"issue":"10","key":"983_CR46","first-page":"1050","volume":"12","author":"V Rolfes","year":"2020","unstructured":"Rolfes V, Ribeiro LS, Hawwari I, B\u00f6ttcher L, Rosero N, Maasewerd S, et al. Platelets fuel the inflammasome activation of innate immune cells. Cell Rep. 2020;12(10):1050\u201366.","journal-title":"Cell Rep"},{"key":"983_CR47","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.705325","volume":"12","author":"G Zhang","year":"2021","unstructured":"Zhang G, Chen H, Guo Y, Zhang W, Jiang Q, Zhang S, Han L, Chen S, Xue R. Activation of platelet NLRP3 inflammasome in Crohn\u2019s disease. Front Pharmacol. 2021;12: 705325.","journal-title":"Front Pharmacol"},{"issue":"6","key":"983_CR48","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1136\/gut.31.6.686","volume":"31","author":"M Ligumsky","year":"1990","unstructured":"Ligumsky M, Simon PL, Karmeli F, Rachmilewitz D. Role of interleukin 1 in inflammatory bowel disease\u2013enhanced production during active disease. Gut. 1990;31(6):686\u20139.","journal-title":"Gut"},{"issue":"4","key":"983_CR49","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/j.immuni.2007.10.002","volume":"27","author":"T-D Kanneganti","year":"2007","unstructured":"Kanneganti T-D, Lamkanfi M, N\u00fa\u00f1ez G. Intracellular NOD-like receptors in host defense and disease. Immunity. 2007;27(4):549\u201359.","journal-title":"Immunity"},{"issue":"4","key":"983_CR50","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1136\/gutjnl-2012-303329","volume":"63","author":"M Bersudsky","year":"2014","unstructured":"Bersudsky M, Luski L, Fishman D, White RM, Ziv-Sokolovskaya N, Dotan S, et al. Non-redundant properties of IL-1\u03b1 and IL-1\u03b2 during acute colon inflammation in mice. Gut. 2014;63(4):598\u2013609.","journal-title":"Gut"},{"key":"983_CR51","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.750841","volume":"12","author":"H Gao","year":"2021","unstructured":"Gao H, Cao M, Yao Y, Hu W, Sun H, Zhang Y, et al. Dysregulated microbiota-driven gasdermin D activation promotes colitis development by mediating IL-18 release. Front Immunol. 2021;12: 750841.","journal-title":"Front Immunol"},{"issue":"5","key":"983_CR52","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/nri3661","volume":"14","author":"MF Neurath","year":"2014","unstructured":"Neurath MF. Cytokines in inflammatory bowel disease. Nat Rev Immunol. 2014;14(5):329\u201342.","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"983_CR53","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/S1074-7613(00)80596-8","volume":"9","author":"O Adachi","year":"1998","unstructured":"Adachi O, Kawai T, Takeda K, Matsumoto M, Tsutsui H, Sakagami M, et al. Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function. Immunity. 1998;9(1):143\u201350.","journal-title":"Immunity"},{"issue":"1","key":"983_CR54","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1111\/imr.12534","volume":"277","author":"SM Man","year":"2017","unstructured":"Man SM, Karki R, Kanneganti T-D. Molecular mechanisms and functions of pyroptosis, inflammatory caspases and inflammasomes in infectious diseases. Immunol Rev. 2017;277(1):61\u201375.","journal-title":"Immunol Rev"},{"issue":"6","key":"983_CR55","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.1053\/gast.2000.20260","volume":"119","author":"T Kanai","year":"2000","unstructured":"Kanai T, Watanabe M, Okazawa A, Nakamaru K, Okamoto M, Naganuma M, et al. Interleukin 18 is a potent proliferative factor for intestinal mucosal lymphocytes in Crohn\u2019s disease. Gastroenterology. 2000;119(6):1514\u201323.","journal-title":"Gastroenterology"},{"issue":"6","key":"983_CR56","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1016\/j.cell.2015.10.072","volume":"163","author":"R Nowarski","year":"2015","unstructured":"Nowarski R, Jackson R, Gagliani N, de Zoete MR, Palm NW, Bailis W, et al. Epithelial IL-18 equilibrium controls barrier function in colitis. Cell. 2015;163(6):1444\u201356.","journal-title":"Cell"},{"issue":"23","key":"983_CR57","doi-asserted-by":"publisher","first-page":"13249","DOI":"10.1073\/pnas.231473998","volume":"98","author":"B Siegmund","year":"2001","unstructured":"Siegmund B, Lehr HA, Fantuzzi G, Dinarello CA. IL-1 beta -converting enzyme (caspase-1) in intestinal inflammation. Proc Natl Acad Sci U S A. 2001;98(23):13249\u201354.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"983_CR58","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.4049\/jimmunol.1400501","volume":"194","author":"K Oficjalska","year":"2015","unstructured":"Oficjalska K, Raverdeau M, Aviello G, Wade SC, Hickey A, Sheehan KM, et al. Protective role for caspase-11 during acute experimental murine colitis. J Immunol. 2015;194(3):1252\u201360.","journal-title":"J Immunol"},{"issue":"5","key":"983_CR59","doi-asserted-by":"publisher","first-page":"2677","DOI":"10.4049\/jimmunol.1002711","volume":"187","author":"J Qian","year":"2011","unstructured":"Qian J, Chernyavsky AI, Marchenko S, Gindi V, Edwards RA, Grando SA. Cytokine-induced alterations of \u03b17 nicotinic receptor in colonic CD4 T cells mediate dichotomous response to nicotine in murine models of Th1\/Th17- versus Th2-mediated colitis. J Immunol. 2011;187(5):2677\u201387.","journal-title":"J Immunol"},{"issue":"7634","key":"983_CR60","doi-asserted-by":"publisher","first-page":"S97","DOI":"10.1038\/540S97a","volume":"540","author":"R Hodson","year":"2016","unstructured":"Hodson R. Inflammatory bowel disease. Nature. 2016;540(7634):S97.","journal-title":"Nature"},{"issue":"8342","key":"983_CR61","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/S0140-6736(83)90129-0","volume":"2","author":"JE Lennard-Jones","year":"1983","unstructured":"Lennard-Jones JE, Morson BC, Ritchie JK, Williams CB. Cancer surveillance in ulcerative colitis. Experience over 15 years. Lancet. 1983;2(8342):149\u201352.","journal-title":"Lancet"},{"issue":"27","key":"983_CR62","doi-asserted-by":"publisher","first-page":"4280","DOI":"10.3748\/wjg.14.4280","volume":"14","author":"F Sanchez-Munoz","year":"2008","unstructured":"Sanchez-Munoz F, Dominguez-Lopez A, Yamamoto-Furusho JK. Role of cytokines in inflammatory bowel disease. World J Gastroenterol. 2008;14(27):4280\u20138.","journal-title":"World J Gastroenterol"},{"issue":"6","key":"983_CR63","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.3390\/molecules26061725","volume":"26","author":"Q Xu","year":"2021","unstructured":"Xu Q, Zhou X, Strober W, Mao L. Inflammasome regulation: therapeutic potential for inflammatory bowel disease. Molecules. 2021;26(6):1725.","journal-title":"Molecules"},{"issue":"10","key":"983_CR64","doi-asserted-by":"publisher","first-page":"2843","DOI":"10.7150\/thno.33727","volume":"9","author":"J Zhao","year":"2019","unstructured":"Zhao J, Gao W, Cai X, Xu J, Zou D, Li Z, et al. Nanozyme-mediated catalytic nanotherapy for inflammatory bowel disease. Theranostics. 2019;9(10):2843\u201355.","journal-title":"Theranostics"},{"issue":"8","key":"983_CR65","first-page":"4218","volume":"130","author":"K Bulek","year":"2020","unstructured":"Bulek K, Zhao J, Liao Y, Rana N, Corridoni D, Antanaviciute A, et al. Epithelial-derived gasdermin D mediates nonlytic IL-1\u03b2 release during experimental colitis. J Clin Invest. 2020;130(8):4218\u201334.","journal-title":"J Clin Invest"},{"issue":"21","key":"983_CR66","doi-asserted-by":"publisher","first-page":"eaaz6717","DOI":"10.1126\/sciadv.aaz6717","volume":"6","author":"C Ma","year":"2020","unstructured":"Ma C, Yang D, Wang B, Wu Y, Li S, Liu X, et al. Gasdermin D in macrophages restrains colitis by controlling cGAS-mediated inflammation. Sci Adv. 2020;6(21):eaaz6717.","journal-title":"Sci Adv"},{"issue":"1","key":"983_CR67","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1038\/s41420-022-01101-6","volume":"8","author":"L Lu","year":"2022","unstructured":"Lu L, Zhang Y, Tan X, Merkher Y, Leonov S, Zhu L, et al. Emerging mechanisms of pyroptosis and its therapeutic strategy in cancer. Cell Death Discov. 2022;8(1):338.","journal-title":"Cell Death Discov"},{"issue":"3","key":"983_CR68","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/s41577-019-0228-2","volume":"20","author":"P Broz","year":"2020","unstructured":"Broz P, Pelegr\u00edn P, Shao F. The gasdermins, a protein family executing cell death and inflammation. The gasdermins, a protein family. Nat Rev Immunol. 2020;20(3):143\u201357.","journal-title":"Nat Rev Immunol"},{"issue":"44","key":"983_CR69","doi-asserted-by":"publisher","first-page":"11601","DOI":"10.1021\/acs.jafc.8b02840","volume":"66","author":"L Zheng","year":"2018","unstructured":"Zheng L, Wei H, Yu H, Xing Q, Zou Y, Zhou Y, et al. Fish skin gelatin hydrolysate production by ginger powder induces glutathione synthesis to prevent hydrogen peroxide induced intestinal oxidative stress via the Pept1-P62-Nrf2 cascade. J Agric Food Chem. 2018;66(44):11601\u201311.","journal-title":"J Agric Food Chem"},{"key":"983_CR70","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2021.108405","volume":"102","author":"L Wang","year":"2022","unstructured":"Wang L, Dong X, Feng S, Pan H, Jang X, Chen L, et al. VX765 alleviates dextran sulfate sodium-induced colitis in mice by suppressing caspase-1-mediated pyroptosis. Int Immunopharmacol. 2022;102: 108405.","journal-title":"Int Immunopharmacol"},{"key":"983_CR71","doi-asserted-by":"publisher","first-page":"4647","DOI":"10.2147\/IJN.S413149","volume":"18","author":"J Huang","year":"2023","unstructured":"Huang J, Dai M, He M, Bu W, Cao L, Jing J, et al. Treatment of ulcerative colitis by cationic liposome delivered NLRP3 siRNA. Int J Nanomedicine. 2023;18:4647\u201362.","journal-title":"Int J Nanomedicine"},{"key":"983_CR72","doi-asserted-by":"publisher","first-page":"1734","DOI":"10.3389\/fimmu.2017.01734","volume":"8","author":"L Duan","year":"2017","unstructured":"Duan L, Rao X, Braunstein Z, Toomey AC, Zhong J. Role of incretin axis in inflammatory bowel disease. Front Immunol. 2017;8:1734.","journal-title":"Front Immunol"},{"issue":"4","key":"983_CR73","doi-asserted-by":"publisher","first-page":"2111","DOI":"10.1172\/JCI133264","volume":"130","author":"Y Xie","year":"2020","unstructured":"Xie Y, Zhao Y, Shi L, Li W, Chen K, Li M, et al. Gut epithelial TSC1\/mTOR controls RIPK3-dependent necroptosis in intestinal inflammation and cancer. J Clin Investig. 2020;130(4):2111\u201328.","journal-title":"J Clin Investig"},{"issue":"6","key":"983_CR74","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1084\/jem.20160462","volume":"214","author":"V Neudecker","year":"2017","unstructured":"Neudecker V, Haneklaus M, Jensen O, Khailova L, Masterson JC, Tye H, et al. Myeloid-derived miR-223 regulates intestinal inflammation via repression of the NLRP3 inflammasome. J Exp Med. 2017;214(6):1737\u201352.","journal-title":"J Exp Med"},{"issue":"2","key":"983_CR75","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.molcel.2012.11.009","volume":"49","author":"BF Py","year":"2013","unstructured":"Py BF, Kim M-S, Vakifahmetoglu-Norberg H, Yuan J. Deubiquitination of NLRP3 by BRCC3 critically regulates inflammasome activity. Mol Cell. 2013;49(2):331\u20138.","journal-title":"Mol Cell"},{"issue":"10","key":"983_CR76","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1080\/15548627.2017.1356977","volume":"13","author":"SH Kim","year":"2017","unstructured":"Kim SH, Kim G, Han DH, Lee M, Kim I, Kim B, et al. Ezetimibe ameliorates steatohepatitis via AMP activated protein kinase-TFEB-mediated activation of autophagy and NLRP3 inflammasome inhibition. Autophagy. 2017;13(10):1767\u201381.","journal-title":"Autophagy"},{"issue":"6","key":"983_CR77","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1080\/08923973.2018.1469145","volume":"40","author":"Y Wang","year":"2018","unstructured":"Wang Y, Tang Q, Duan P, Yang L. Curcumin as a therapeutic agent for blocking NF-\u03baB activation in ulcerative colitis. Immunopharmacol Immunotoxicol. 2018;40(6):476\u201382.","journal-title":"Immunopharmacol Immunotoxicol"},{"issue":"2","key":"983_CR78","doi-asserted-by":"publisher","DOI":"10.1128\/Spectrum.00730-21","volume":"9","author":"S Qu","year":"2021","unstructured":"Qu S, Fan L, Qi Y, Xu C, Hu Y, Chen S, et al. Akkermansia muciniphila alleviates dextran sulfate sodium (DSS)-induced acute colitis by NLRP3 activation. Microbiol Spectr. 2021;9(2): e0073021.","journal-title":"Microbiol Spectr"},{"issue":"17","key":"983_CR79","doi-asserted-by":"publisher","first-page":"8570","DOI":"10.7150\/thno.62046","volume":"11","author":"L Tong","year":"2021","unstructured":"Tong L, Hao H, Zhang Z, Lv Y, Liang X, Liu Q, et al. Milk-derived extracellular vesicles alleviate ulcerative colitis by regulating the gut immunity and reshaping the gut microbiota. Theranostics. 2021;11(17):8570\u201386.","journal-title":"Theranostics"},{"issue":"1","key":"983_CR80","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.taap.2014.10.002","volume":"281","author":"X-F Wu","year":"2014","unstructured":"Wu X-F, Ouyang Z-J, Feng L-L, Chen G, Guo W-J, Shen Y, et al. Suppression of NF-\u03baB signaling and NLRP3 inflammasome activation in macrophages is responsible for the amelioration of experimental murine colitis by the natural compound fraxinellone. Toxicol Appl Pharmacol. 2014;281(1):146\u201356.","journal-title":"Toxicol Appl Pharmacol"},{"key":"983_CR81","doi-asserted-by":"publisher","first-page":"28370","DOI":"10.1038\/srep28370","volume":"6","author":"X He","year":"2016","unstructured":"He X, Wei Z, Wang J, Kou J, Liu W, Fu Y, et al. Alpinetin attenuates inflammatory responses by suppressing TLR4 and NLRP3 signaling pathways in DSS-induced acute colitis. Sci Rep. 2016;6:28370.","journal-title":"Sci Rep"},{"issue":"6","key":"983_CR82","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1038\/emm.2007.78","volume":"39","author":"HW Jung","year":"2007","unstructured":"Jung HW, Chung YS, Kim YS, Park Y-K. Celastrol inhibits production of nitric oxide and proinflammatory cytokines through MAPK signal transduction and NF-kappaB in LPS-stimulated BV-2 microglial cells. Exp Mol Med. 2007;39(6):715\u201321.","journal-title":"Exp Mol Med"},{"issue":"5","key":"983_CR83","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1038\/s41385-019-0177-x","volume":"12","author":"Y Zhao","year":"2019","unstructured":"Zhao Y, Guo Q, Zhu Q, Tan R, Bai D, Bu X, et al. Flavonoid VI-16 protects against DSS-induced colitis by inhibiting Txnip-dependent NLRP3 inflammasome activation in macrophages via reducing oxidative stress. Mucosal Immunol. 2019;12(5):1150\u201363.","journal-title":"Mucosal Immunol"},{"issue":"1","key":"983_CR84","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1021\/acs.jmedchem.0c01924","volume":"64","author":"Z Dai","year":"2021","unstructured":"Dai Z, Chen X-Y, An L-Y, Li C-C, Zhao N, Yang F, et al. Development of novel tetrahydroquinoline inhibitors of NLRP3 inflammasome for potential treatment of DSS-induced mouse colitis. J Med Chem. 2021;64(1):871\u201389.","journal-title":"J Med Chem"},{"issue":"28","key":"983_CR85","doi-asserted-by":"publisher","first-page":"33322","DOI":"10.1021\/acsami.3c04206","volume":"15","author":"R Negro","year":"2023","unstructured":"Negro R, Mastrogiacomo R, Carrieri L, Rizzi F, Arr\u00e8 V, Minervini G, et al. Encapsulation of MCC950 in liposomes decorated with anti-frizzled 1 improves drug bioavailability and effectiveness in fatty liver disease. ACS Appl Mater. 2023;15(28):33322\u201334.","journal-title":"ACS Appl Mater"},{"issue":"1","key":"983_CR86","doi-asserted-by":"publisher","first-page":"8618","DOI":"10.1038\/s41598-018-26775-w","volume":"8","author":"AP Perera","year":"2018","unstructured":"Perera AP, Fernando R, Shinde T, Gundamaraju R, Southam B, Sohal SS, et al. MCC950, a specific small molecule inhibitor of NLRP3 inflammasome attenuates colonic inflammation in spontaneous colitis mice. Sci Rep. 2018;8(1):8618.","journal-title":"Sci Rep"},{"issue":"3","key":"983_CR87","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1111\/jgh.12710","volume":"30","author":"S Wang","year":"2015","unstructured":"Wang S, Zhang Y, Saas P, Wang H, Xu Y, Chen K, et al. Oridonin\u2019s therapeutic effect: suppressing Th1\/Th17 simultaneously in a mouse model of Crohn\u2019s disease. J Gastroenterol Hepatol. 2015;30(3):504\u201312.","journal-title":"J Gastroenterol Hepatol"},{"issue":"9","key":"983_CR88","doi-asserted-by":"publisher","first-page":"3656","DOI":"10.1021\/acs.jmedchem.6b01624","volume":"60","author":"M Cocco","year":"2017","unstructured":"Cocco M, Pellegrini C, Mart\u00ednez-Banaclocha H, Giorgis M, Marini E, Costale A, et al. Development of an acrylate derivative targeting the NLRP3 inflammasome for the treatment of inflammatory bowel disease. J Med Chem. 2017;60(9):3656\u201371.","journal-title":"J Med Chem"},{"issue":"7","key":"983_CR89","doi-asserted-by":"publisher","first-page":"2912","DOI":"10.1007\/s10620-021-07184-y","volume":"67","author":"T Oizumi","year":"2022","unstructured":"Oizumi T, Mayanagi T, Toya Y, Sugai T, Matsumoto T, Sobue K. NLRP3 inflammasome inhibitor OLT1177 suppresses onset of inflammation in mice with dextran sulfate sodium-induced colitis. Dig Dis Sci. 2022;67(7):2912\u201321.","journal-title":"Dig Dis Sci"},{"issue":"6","key":"983_CR90","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1038\/s41423-021-00683-y","volume":"18","author":"Y Chen","year":"2021","unstructured":"Chen Y, He H, Lin B, Chen Y, Deng X, Jiang W, et al. RRx-001 ameliorates inflammatory diseases by acting as a potent covalent NLRP3 inhibitor. Cell Mol Immunol. 2021;18(6):1425\u201336.","journal-title":"Cell Mol Immunol"},{"issue":"10","key":"983_CR91","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1016\/j.bcp.2013.03.008","volume":"85","author":"W Liu","year":"2013","unstructured":"Liu W, Guo W, Wu J, Luo Q, Tao F, Gu Y, et al. A novel benzo[d]imidazole derivate prevents the development of dextran sulfate sodium-induced murine experimental colitis via inhibition of NLRP3 inflammasome. Biochem Pharmacol. 2013;85(10):1504\u201312.","journal-title":"Biochem Pharmacol"},{"key":"983_CR92","doi-asserted-by":"publisher","first-page":"370","DOI":"10.3389\/fimmu.2013.00370","volume":"4","author":"AM Janowski","year":"2013","unstructured":"Janowski AM, Kolb R, Zhang W, Sutterwala FS. Beneficial and detrimental roles of NLRs in carcinogenesis. Front Immunol. 2013;4:370.","journal-title":"Front Immunol"},{"issue":"5","key":"983_CR93","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1016\/j.ccr.2008.10.011","volume":"14","author":"S Tu","year":"2008","unstructured":"Tu S, Bhagat G, Cui G, Takaishi S, Kurt-Jones EA, Rickman B, et al. Overexpression of interleukin-1beta induces gastric inflammation and cancer and mobilizes myeloid-derived suppressor cells in mice. Cancer Cell. 2008;14(5):408\u201319.","journal-title":"Cancer Cell"},{"issue":"10","key":"983_CR94","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1038\/ni.2703","volume":"14","author":"TF Gajewski","year":"2013","unstructured":"Gajewski TF, Schreiber H, Fu Y-X. Innate and adaptive immune cells in the tumor microenvironment. Nat Immunol. 2013;14(10):1014\u201322.","journal-title":"Nat Immunol"},{"issue":"16","key":"983_CR95","doi-asserted-by":"publisher","first-page":"5393","DOI":"10.1158\/0008-5472.CAN-11-0993","volume":"71","author":"M Terme","year":"2011","unstructured":"Terme M, Ullrich E, Aymeric L, Meinhardt K, Desbois M, Delahaye N, et al. IL-18 induces PD-1-dependent immunosuppression in cancer. Cancer Res. 2011;71(16):5393\u20139.","journal-title":"Cancer Res"},{"issue":"6","key":"983_CR96","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1084\/jem.20161707","volume":"214","author":"D Daley","year":"2017","unstructured":"Daley D, Mani VR, Mohan N, Akkad N, Pandian GSDB, Savadkar S, et al. NLRP3 signaling drives macrophage-induced adaptive immune suppression in pancreatic carcinoma. J Exp Med. 2017;214(6):1711\u201324.","journal-title":"J Exp Med"},{"issue":"4","key":"983_CR97","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1016\/j.cell.2016.11.037","volume":"168","author":"AW Lambert","year":"2017","unstructured":"Lambert AW, Pattabiraman DR, Weinberg RA. Emerging biological principles of metastasis. Cell. 2017;168(4):670\u201391.","journal-title":"Cell"},{"issue":"22","key":"983_CR98","doi-asserted-by":"publisher","first-page":"5721","DOI":"10.1158\/0008-5472.CAN-12-0509","volume":"72","author":"MT Chow","year":"2012","unstructured":"Chow MT, Sceneay J, Paget C, Wong CSF, Duret H, Tschopp J, et al. NLRP3 suppresses NK cell-mediated responses to carcinogen-induced tumors and metastases. Cancer Res. 2012;72(22):5721\u201332.","journal-title":"Cancer Res"},{"issue":"19","key":"983_CR99","doi-asserted-by":"publisher","first-page":"6018","DOI":"10.1158\/1078-0432.CCR-09-0011","volume":"15","author":"MA St. John","year":"2009","unstructured":"St. John MA, Dohadwala M, Luo J, Wang G, Lee G, Shih H, et al. Proinflammatory mediators upregulate snail in head and neck squamous cell carcinoma. Clin Cancer Res. 2009;15(19):6018\u201327.","journal-title":"Clin Cancer Res"},{"issue":"6","key":"983_CR100","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394\u2013424.","journal-title":"CA Cancer J Clin"},{"issue":"10","key":"983_CR101","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1002\/jat.4332","volume":"42","author":"Q Liu","year":"2022","unstructured":"Liu Q, Zhao C, Zhou J, Zhang H, Zhang Y, Wang S, et al. Reactive oxygen species-mediated activation of NLRP3 inflammasome associated with pyroptosis in Het-1A cells induced by the co-exposure of nitrosamines. J Appl Toxicol. 2022;42(10):1651\u201361.","journal-title":"J Appl Toxicol"},{"issue":"4","key":"983_CR102","first-page":"1113","volume":"43","author":"S Yu","year":"2020","unstructured":"Yu S, Yin J-J, Miao J-X, Li S-G, Huang C-Z, Huang N, et al. Activation of NLRP3 inflammasome promotes the proliferation and migration of esophageal squamous cell carcinoma. Oncol Rep. 2020;43(4):1113\u201324.","journal-title":"Oncol Rep"},{"key":"983_CR103","doi-asserted-by":"publisher","first-page":"1074606","DOI":"10.3389\/fimmu.2023.1074606","volume":"14","author":"J Wen","year":"2023","unstructured":"Wen J, Xuan B, Liu Y, Wang L, He L, Meng X, et al. NLRP3 inflammasome-induced pyroptosis in digestive system tumors. Front Immunol. 2023;14:1074606.","journal-title":"Front Immunol"},{"issue":"12","key":"983_CR104","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.3748\/wjg.v28.i12.1187","volume":"28","author":"M Ilic","year":"2022","unstructured":"Ilic M, Ilic I. Epidemiology of stomach cancer. World J Gastroenterol. 2022;28(12):1187\u2013203.","journal-title":"World J Gastroenterol"},{"issue":"6","key":"983_CR105","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1080\/19490976.2015.1105427","volume":"6","author":"KN Koch","year":"2015","unstructured":"Koch KN, Anne MA. Helicobacter pylori activates the TLR2\/NLRP3\/caspase-1\/IL-18 axis to induce regulatory T-cells, establish persistent infection and promote tolerance to allergens. Gut Microbes. 2015;6(6):382\u2013327.","journal-title":"Gut Microbes"},{"issue":"7","key":"983_CR106","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1038\/onc.2017.381","volume":"37","author":"S Li","year":"2018","unstructured":"Li S, Liang X, Ma L, Shen L, Li T, Zheng L, et al. MiR-22 sustains NLRP3 expression and attenuates H. pylori-induced gastric carcinogenesis. Oncogene. 2018;37(7):884\u201396.","journal-title":"Oncogene"},{"issue":"3","key":"983_CR107","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/gene.2016.10","volume":"17","author":"GZ Ng","year":"2016","unstructured":"Ng GZ, Sutton P. The MUC1 mucin specifically inhibits activation of the NLRP3 inflammasome. Genes Immun. 2016;17(3):203\u20136.","journal-title":"Genes Immun"},{"issue":"11","key":"983_CR108","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0077955","volume":"8","author":"Y Xu","year":"2013","unstructured":"Xu Y, Li H, Chen W, Yao X, Xing Y, Wang X, et al. Mycoplasma hyorhinis activates the NLRP3 inflammasome and promotes migration and invasion of gastric cancer cells. PLoS ONE. 2013;8(11): e77955.","journal-title":"PLoS ONE"},{"issue":"3","key":"983_CR109","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.4049\/jimmunol.1201959","volume":"190","author":"W Wang","year":"2013","unstructured":"Wang W, Wang X, Chun J, Vilaysane A, Clark S, French G, et al. Inflammasome-independent NLRP3 augments TGF-\u03b2 signaling in kidney epithelium. J Immunol. 2013;190(3):1239\u201349.","journal-title":"J Immunol"},{"issue":"6776","key":"983_CR110","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1038\/35006081","volume":"404","author":"EM El-Omar","year":"2000","unstructured":"El-Omar EM, Carrington M, Chow WH, McColl KE, Bream JH, Young HA, et al. Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature. 2000;404(6776):398\u2013402.","journal-title":"Nature"},{"issue":"12","key":"983_CR111","doi-asserted-by":"publisher","first-page":"1987","DOI":"10.1093\/carcin\/bgp158","volume":"30","author":"JS Kang","year":"2009","unstructured":"Kang JS, Bae SY, Kim HR, Kim YS, Kim DJ, Cho BJ, et al. Interleukin-18 increases metastasis and immune escape of stomach cancer via the downregulation of CD70 and maintenance of CD44. Carcinogenesis. 2009;30(12):1987\u201396.","journal-title":"Carcinogenesis"},{"issue":"2","key":"983_CR112","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1158\/2326-6066.CIR-16-0269","volume":"5","author":"R Karki","year":"2017","unstructured":"Karki R, Man SM, Kanneganti T-D. Inflammasomes and cancer. Cancer Immunol Res. 2017;5(2):94\u20139.","journal-title":"Cancer Immunol Res"},{"issue":"2","key":"983_CR113","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1111\/1751-2980.12576","volume":"19","author":"WJ Wang","year":"2018","unstructured":"Wang WJ, Chen D, Jiang MZ, Xu B, Li XW, Chu Y, et al. Downregulation of gasdermin D promotes gastric cancer proliferation by regulating cell cycle-related proteins. J Dig Dis. 2018;19(2):74\u201383.","journal-title":"J Dig Dis"},{"issue":"11","key":"983_CR114","doi-asserted-by":"publisher","first-page":"11025","DOI":"10.18632\/aging.103314","volume":"12","author":"N Ren","year":"2020","unstructured":"Ren N, Jiang T, Wang C, Xie S, Xing Y, Piao D, Zhang T, Zhu Y. LncRNA ADAMTS9-AS2 inhibits gastric cancer (GC) development and sensitizes chemoresistant GC cells to cisplatin by regulating miR-223-3p\/NLRP3 axis. Aging (Albany NY). 2020;12(11):11025\u201341.","journal-title":"Aging (Albany NY)"},{"issue":"12","key":"983_CR115","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1038\/s41575-018-0054-1","volume":"15","author":"SM Man","year":"2018","unstructured":"Man SM. Inflammasomes in the gastrointestinal tract: infection, cancer and gut microbiota homeostasis. Nat Rev Gastroenterol Hepatol. 2018;15(12):721\u201337.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"9","key":"983_CR116","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1136\/gut.2009.197822","volume":"59","author":"C Bauer","year":"2010","unstructured":"Bauer C, Duewell P, Mayer C, Lehr HA, Fitzgerald KA, Dauer M, et al. Colitis induced in mice with dextran sulfate sodium (DSS) is mediated by the NLRP3 inflammasome. Gut. 2010;59(9):1192\u2013999.","journal-title":"Gut"},{"issue":"33","key":"983_CR117","doi-asserted-by":"publisher","first-page":"4796","DOI":"10.3748\/wjg.v25.i33.4796","volume":"25","author":"E Tourkochristou","year":"2019","unstructured":"Tourkochristou E, Aggeletopoulou I, Konstantakis C, Triantos C. Role of NLRP3 inflammasome in inflammatory bowel diseases. World J Gastroenterol. 2019;25(33):4796\u2013804.","journal-title":"World J Gastroenterol"},{"issue":"4","key":"983_CR118","first-page":"483","volume":"24","author":"Y Marandi","year":"2021","unstructured":"Marandi Y, Hashemzade S, Tayebinia H, Karimi J, Zamani A, Khodadadi I. NLRP3-inflammasome activation is associated with epithelial-mesenchymal transition and progression of colorectal cancer. Iran J Basic Med Sci. 2021;24(4):483\u201392.","journal-title":"Iran J Basic Med Sci"},{"key":"983_CR119","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.3389\/fimmu.2020.01444","volume":"11","author":"S Hamarsheh","year":"2020","unstructured":"Hamarsheh S, Zeiser R. NLRP3 inflammasome activation in cancer: a double-edged sword. Front Immunol. 2020;11:1444.","journal-title":"Front Immunol"},{"issue":"28","key":"983_CR120","doi-asserted-by":"publisher","first-page":"25975","DOI":"10.18632\/oncotarget.4543","volume":"6","author":"H Sui","year":"2015","unstructured":"Sui H, Xu H, Ji Q, Liu X, Zhou L, Song H, et al. 5-hydroxytryptamine receptor (5-HT1DR) promotes colorectal cancer metastasis by regulating Axin1\/\u03b2-catenin\/MMP-7 signaling pathway. Oncotarget. 2015;6(28):25975\u201387.","journal-title":"Oncotarget"},{"issue":"9","key":"983_CR121","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1158\/2326-6066.CIR-20-1043","volume":"9","author":"T Li","year":"2021","unstructured":"Li T, Fu B, Zhang X, Zhou Y, Yang M, Cao M, et al. Overproduction of gastrointestinal 5-HT promotes colitis-associated colorectal cancer progression via enhancing NLRP3 inflammasome activation. Cancer Immunol Res. 2021;9(9):1008\u201323.","journal-title":"Cancer Immunol Res"},{"issue":"10","key":"983_CR122","doi-asserted-by":"publisher","first-page":"2745","DOI":"10.1158\/0008-5472.CAN-20-3827","volume":"81","author":"X Wang","year":"2021","unstructured":"Wang X, Jia Y, Wen L, Mu W, Wu X, Liu T, et al. Porphyromonas gingivalis promotes colorectal carcinoma by activating the hematopoietic NLRP3 inflammasome. Cancer Res. 2021;81(10):2745\u201359.","journal-title":"Cancer Res"},{"issue":"6","key":"983_CR123","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1016\/j.cell.2010.01.040","volume":"140","author":"K Schroder","year":"2010","unstructured":"Schroder K, Tschopp J. The inflammasomes. Cell. 2010;140(6):821\u201332.","journal-title":"Cell"},{"issue":"2","key":"983_CR124","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1159\/000477890","volume":"42","author":"C Wang","year":"2017","unstructured":"Wang C, Li P, Xuan J, Zhu C, Liu J, Shan L, et al. Cholesterol enhances colorectal cancer progression via ROS elevation and MAPK signaling pathway activation. Cell Physiol Biochem. 2017;42(2):729\u201342.","journal-title":"Cell Physiol Biochem"},{"issue":"11","key":"983_CR125","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.1093\/carcin\/bgs256","volume":"33","author":"J Ungerb\u00e4ck","year":"2012","unstructured":"Ungerb\u00e4ck J, Belenki D, Ul-Hassan AJ, Fredrikson M, Frans\u00e9n K, Elander N, et al. Genetic variation and alterations of genes involved in NF\u03baB\/TNFAIP3- and NLRP3-inflammasome signaling affect susceptibility and outcome of colorectal cancer. Carcinogenesis. 2012;33(11):2126\u201334.","journal-title":"Carcinogenesis"},{"key":"983_CR126","doi-asserted-by":"publisher","first-page":"10397","DOI":"10.2147\/CMAR.S244374","volume":"12","author":"L-S Wu","year":"2020","unstructured":"Wu L-S, Liu Y, Wang X-W, Xu B, Lin Y-L, Song Y, et al. LPS enhances the chemosensitivity of oxaliplatin in HT29 cells via GSDMD-mediated pyroptosis. Cancer Manag Res. 2020;12:10397\u2013409.","journal-title":"Cancer Manag Res"},{"issue":"4","key":"983_CR127","first-page":"341","volume":"44","author":"V Brock","year":"2012","unstructured":"Brock V, Fukunaga T, Amano T, Shiroishi T. Gasdermin D represses inflammation-induced colon cancer development by regulating apoptosis Get access Arrow. Carcinogenesis. 2012;44(4):341\u20139.","journal-title":"Carcinogenesis"},{"issue":"1","key":"983_CR128","doi-asserted-by":"publisher","first-page":"4","DOI":"10.4161\/gmic.19320","volume":"3","author":"H-J Wu","year":"2012","unstructured":"Wu H-J, Wu E. The role of gut microbiota in immune homeostasis and autoimmunity. Gut Microbes. 2012;3(1):4\u201314.","journal-title":"Gut Microbes"},{"issue":"3","key":"983_CR129","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.immuni.2010.03.003","volume":"32","author":"MH Zaki","year":"2010","unstructured":"Zaki MH, Boyd KL, Vogel P, Kastan MB, Lamkanfi M, Kanneganti T-D. The NLRP3 inflammasome protects against loss of epithelial integrity and mortality during experimental colitis. Immunity. 2010;32(3):379\u201391.","journal-title":"Immunity"},{"issue":"1","key":"983_CR130","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/s41572-020-00240-3","volume":"7","author":"JM Llovet","year":"2021","unstructured":"Llovet JM, Kelley RK, Villanueva A, Singal AG, Pikarsky E, Roayaie S, et al. Hepatocellular carcinoma. Nat Rev Dis Primers. 2021;7(1):6.","journal-title":"Nat Rev Dis Primers"},{"issue":"1","key":"983_CR131","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1038\/labinvest.2013.126","volume":"94","author":"Q Wei","year":"2014","unstructured":"Wei Q, Mu K, Li T, Zhang Y, Yang Z, Jia X, et al. Deregulation of the NLRP3 inflammasome in hepatic parenchymal cells during liver cancer progression. Lab Invest. 2014;94(1):52\u201362.","journal-title":"Lab Invest"},{"issue":"51","key":"983_CR132","doi-asserted-by":"publisher","first-page":"84658","DOI":"10.18632\/oncotarget.12384","volume":"7","author":"Q Chu","year":"2016","unstructured":"Chu Q, Jiang Y, Zhang W, Xu C, Du W, Tuguzbaeva G, et al. Pyroptosis is involved in the pathogenesis of human hepatocellular carcinoma. Oncotarget. 2016;7(51):84658\u201365.","journal-title":"Oncotarget"},{"issue":"7","key":"983_CR133","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1038\/labinvest.2015.63","volume":"95","author":"Q Wei","year":"2015","unstructured":"Wei Q, Guo P, Mu K, Zhang Y, Zhao W, Huai W, et al. Estrogen suppresses hepatocellular carcinoma cells through ER\u03b2-mediated upregulation of the NLRP3 inflammasome. Lab Invest. 2015;95(7):804\u201316.","journal-title":"Lab Invest"},{"issue":"2","key":"983_CR134","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0089961","volume":"9","author":"S-H Fan","year":"2014","unstructured":"Fan S-H, Wang Y-Y, Lu J, Zheng Y-L, Wu D-M, Li M-Q, et al. Luteoloside suppresses proliferation and metastasis of hepatocellular carcinoma cells by inhibition of NLRP3 inflammasome. PLoS ONE. 2014;9(2): e89961.","journal-title":"PLoS ONE"},{"key":"983_CR135","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.2147\/DDDT.S243383","volume":"14","author":"P Li","year":"2020","unstructured":"Li P, Liu Y, He Q. Anisodamine suppressed the growth of hepatocellular carcinoma cells, induced apoptosis and regulated the levels of inflammatory factors by inhibiting NLRP3 inflammasome activation. Drug Des Devel Ther. 2020;14:1609\u201320.","journal-title":"Drug Des Devel Ther"},{"issue":"3","key":"983_CR136","first-page":"2429","volume":"15","author":"L Wan","year":"2018","unstructured":"Wan L, Yuan X, Liu M, Xue B. miRNA-223-3p regulates NLRP3 to promote apoptosis and inhibit proliferation of hep3B cells. Exp Ther Med. 2018;15(3):2429\u201335.","journal-title":"Exp Ther Med"},{"issue":"1","key":"983_CR137","doi-asserted-by":"publisher","first-page":"5847","DOI":"10.1038\/s41467-020-19554-7","volume":"11","author":"CN Brocker","year":"2011","unstructured":"Brocker CN, Kim D, Melia T, Karri K, Velenosi TJ, Takahashi S, et al. Long non-coding RNA Gm15441 attenuates hepatic inflammasome activation in response to PPARA agonism and fasting. Nat Commun. 2011;11(1):5847.","journal-title":"Nat Commun"},{"issue":"17","key":"983_CR138","doi-asserted-by":"publisher","first-page":"9285","DOI":"10.3390\/ijms22179285","volume":"22","author":"HH Lee","year":"2021","unstructured":"Lee HH, Kim D, Jung J, Kang H, Cho H. NLRP3 deficiency in hepatocellular carcinoma enhances surveillance of NK-92 through a modulation of MICA\/B. Int J Mol Sci. 2021;22(17):9285.","journal-title":"Int J Mol Sci"},{"issue":"6","key":"983_CR139","doi-asserted-by":"publisher","first-page":"e004763","DOI":"10.1136\/jitc-2022-004763","volume":"10","author":"T Lv","year":"2022","unstructured":"Lv T, Xiong X, Yan W, Liu M, Xu H, He Q. Targeting of GSDMD sensitizes HCC to anti-PD-1 by activating cGAS pathway and downregulating PD-L1 expression. J Immunother Cancer. 2022;10(6):e004763.","journal-title":"J Immunother Cancer"},{"issue":"4","key":"983_CR140","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/j.jhep.2004.06.027","volume":"41","author":"T Toyama","year":"2004","unstructured":"Toyama T, Sasaki Y, Horimoto M, Iyoda K, Yakushijin T, Ohkawa K, et al. Ninjurin1 increases p21 expression and induces cellular senescence in human hepatoma cells. J Hepatol. 2004;41(4):637\u201343.","journal-title":"J Hepatol"},{"issue":"1","key":"983_CR141","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1002\/hep.24351","volume":"54","author":"GL Tyson","year":"2011","unstructured":"Tyson GL, El-Serag HB. Risk factors of cholangiocarcinoma. Hepatology. 2011;54(1):173\u201384.","journal-title":"Hepatology"},{"key":"983_CR142","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1111\/jgh.12711","volume":"30","author":"H Matsushita","year":"2015","unstructured":"Matsushita H, Miyake Y, Takaki A, Yasunaka T, Koike K, Ikeda F, et al. TLR4, TLR9, and NLRP3 in biliary epithelial cells of primary sclerosing cholangitis: relationship with clinical characteristics. J Gastroenterol Hepatol. 2015;30:600\u20138.","journal-title":"J Gastroenterol Hepatol"},{"key":"983_CR143","doi-asserted-by":"publisher","first-page":"107","DOI":"10.3389\/fimmu.2012.00107","volume":"3","author":"DC Rubin","year":"2012","unstructured":"Rubin DC, Shaker A, Levin MS. Chronic intestinal inflammation: inflammatory bowel disease and colitis-associated colon cancer. Front Immunol. 2012;3:107.","journal-title":"Front Immunol"},{"key":"983_CR144","first-page":"99","volume":"6","author":"R Hundal","year":"2014","unstructured":"Hundal R, Shaffer EA. Gallbladder cancer: epidemiology and outcome. Clin Epidemiol. 2014;6:99\u2013109.","journal-title":"Clin Epidemiol"},{"issue":"1","key":"983_CR145","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1038\/s41392-020-00324-2","volume":"5","author":"X Song","year":"2020","unstructured":"Song X, Hu Y, Li Y, Shao R, Liu F, Liu Y. Overview of current targeted therapy in gallbladder cancer. Signal Transduct Target Ther. 2020;5(1):230.","journal-title":"Signal Transduct Target Ther"},{"issue":"6","key":"983_CR146","doi-asserted-by":"publisher","first-page":"113","DOI":"10.3892\/or.2021.8064","volume":"45","author":"Z Zhu","year":"2021","unstructured":"Zhu Z, Zhu Q, Cai D, Chen L, Xie W, Bai Y, et al. Golgi phosphoprotein 3 promotes the proliferation of gallbladder carcinoma cells via regulation of the NLRP3 inflammasome. Oncol Rep. 2021;45(6):113.","journal-title":"Oncol Rep"},{"issue":"6","key":"983_CR147","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1158\/1078-0432.CCR-10-1561","volume":"17","author":"AV Maker","year":"2011","unstructured":"Maker AV, Katabi N, Qin LX, Klimstra DS, Schattner M, Brennan MF, et al. Cyst fluid interleukin-1beta (IL1beta) levels predict the risk of carcinoma in intraductal papillary mucinous neoplasms of the pancreas. Clin Cancer Res. 2011;17(6):1502\u20138.","journal-title":"Clin Cancer Res"},{"issue":"6","key":"983_CR148","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.1080\/19490976.2020.1770042","volume":"11","author":"X Li","year":"2020","unstructured":"Li X, He C, Li N, Ding L, Chen H, Wan J, et al. The interplay between the gut microbiota and NLRP3 activation affects the severity of acute pancreatitis in mice. Gut Microbes. 2020;11(6):1774\u201389.","journal-title":"Gut Microbes"},{"issue":"10","key":"983_CR149","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.1038\/bjc.2013.174","volume":"108","author":"S Mitsunaga","year":"2013","unstructured":"Mitsunaga S, Ikeda M, Shimizu S, Ohno I, Furuse J, Inagaki M, et al. Serum levels of IL-6 and IL-1beta can predict the efficacy of gemcitabine in patients with advanced pancreatic cancer. Br J Cancer. 2013;108(10):2063\u20139.","journal-title":"Br J Cancer"},{"issue":"1","key":"983_CR150","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s12943-018-0761-9","volume":"17","author":"H Hu","year":"2018","unstructured":"Hu H, Wang Y, Ding X, He Y, Lu Z, Wu P, et al. Long non-coding RNA XLOC_000647 suppresses progression of pancreatic cancer and decreases epithelial-mesenchymal transition-induced cell invasion by down-regulating NLRP3. Mol Cancer. 2018;17(1):18.","journal-title":"Mol Cancer"},{"issue":"7","key":"983_CR151","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1007\/s00277-019-03692-0","volume":"98","author":"BA Boone","year":"2019","unstructured":"Boone BA, Murthy P, Miller-Ocuin JL, Liang X, Russell KL, Loughran P, et al. The platelet NLRP3 inflammasome is upregulated in a murine model of pancreatic cancer and promotes platelet aggregation and tumor growth. Ann Hematol. 2019;98(7):1603\u201310.","journal-title":"Ann Hematol"},{"issue":"7","key":"983_CR152","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1007\/s00011-020-01351-z","volume":"69","author":"W-H Xie","year":"2020","unstructured":"Xie W-H, Ding J, Xie X-X, Yang X-H, Wu X-F, Chen Z-X, et al. Hepatitis B virus X protein promotes liver cell pyroptosis under oxidative stress through NLRP3 inflammasome activation. Inflamm Res. 2020;69(7):683\u201396.","journal-title":"Inflamm Res"},{"issue":"1","key":"983_CR153","doi-asserted-by":"publisher","first-page":"893","DOI":"10.3892\/ol.2020.11635","volume":"20","author":"Z Chen","year":"2020","unstructured":"Chen Z, He M, Chen J, Li C, Zhang Q. Long non-coding RNA SNHG7 inhibits NLRP3-dependent pyroptosis by targeting the miR-34a\/SIRT1 axis in liver cancer. Oncol Lett. 2020;20(1):893\u2013901.","journal-title":"Oncol Lett"},{"key":"983_CR154","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2019.109595","volume":"121","author":"Y Fang","year":"2020","unstructured":"Fang Y, Tian S, Pan Y, Li W, Wang Q, Tang Y, et al. Pyroptosis: a new frontier in cancer. Biomed Pharmacother. 2020;121: 109595.","journal-title":"Biomed Pharmacother"},{"key":"983_CR155","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.610545","volume":"10","author":"R Jiang","year":"2021","unstructured":"Jiang R, Chen X, Ge S, Wang Q, Liu Y, Chen H, et al. MiR-21-5p induces pyroptosis in colorectal cancer via TGFBI. Front Oncol. 2021;10: 610545.","journal-title":"Front Oncol"},{"issue":"6","key":"983_CR156","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1158\/1541-7786.MCR-18-0910","volume":"17","author":"J Cui","year":"2019","unstructured":"Cui J, Zhou Z, Yang H, Jiao F, Li N, Gao Y, et al. MST1 suppresses pancreatic cancer progression via ROS-induced pyroptosis. Mol Cancer Res. 2019;17(6):1316\u201325.","journal-title":"Mol Cancer Res"},{"key":"983_CR157","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.canlet.2019.02.014","volume":"450","author":"L Wang","year":"2019","unstructured":"Wang L, Li K, Lin X, Yao Z, Wang S, Xiong X, et al. Metformin induces human esophageal carcinoma cell pyroptosis by targeting the miR-497\/PELP1 axis. Cancer Lett. 2019;450:22\u201331.","journal-title":"Cancer Lett"},{"issue":"9","key":"983_CR158","doi-asserted-by":"publisher","first-page":"2219","DOI":"10.1007\/s00432-020-03274-y","volume":"146","author":"ACK Yaw","year":"2020","unstructured":"Yaw ACK, Chan EWL, Yap JKY, Mai CW. The effects of NLRP3 inflammasome inhibition by MCC950 on LPS-induced pancreatic adenocarcinoma inflammation. J Cancer Res Clin Oncol. 2020;146(9):2219\u201329.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"4","key":"983_CR159","doi-asserted-by":"publisher","first-page":"BSR20210280","DOI":"10.1042\/BSR20210280","volume":"41","author":"F Shi","year":"2021","unstructured":"Shi F, Wei B, Lan T, Xiao Y, Quan X, Chen J, et al. Low NLRP3 expression predicts a better prognosis of colorectal cancer. Biosci Rep. 2021;41(4):BSR20210280.","journal-title":"Biosci Rep"},{"key":"983_CR160","doi-asserted-by":"crossref","unstructured":"Yang J, Liu S, Li Y, Fan Z, Meng Y, Zhou B, et al. FABP4 in macrophages facilitates obesity-associated pancreatic cancer progression via the NLRP3\/IL-1\u03b2 axis. Cancer Lett. 2023;216403.","DOI":"10.1016\/j.canlet.2023.216403"},{"issue":"3","key":"983_CR161","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1016\/j.bbrc.2019.04.011","volume":"513","author":"D Zhang","year":"2019","unstructured":"Zhang D, Zhou Q, Huang D, He L, Zhang H, Hu B, et al. ROS\/JNK\/c-Jun axis is involved in oridonin-induced caspase-dependent apoptosis in human colorectal cancer cells. Biochem Biophys Res Commun. 2019;513(3):594\u2013601.","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"983_CR162","doi-asserted-by":"publisher","first-page":"2499","DOI":"10.3892\/ol.2017.6421","volume":"14","author":"Z He","year":"2017","unstructured":"He Z, Xiao X, Li S, Guo Y, Huang Q, Shi X, et al. Oridonin induces apoptosis and reverses drug resistance in cisplatin resistant human gastric cancer cells. Oncol Lett. 2017;14(2):2499\u2013504.","journal-title":"Oncol Lett"},{"issue":"2","key":"983_CR163","doi-asserted-by":"publisher","first-page":"805","DOI":"10.3390\/molecules28020805","volume":"28","author":"X Zhang","year":"2023","unstructured":"Zhang X, Xing M, Ma Y, Zhang Z, Qiu C, Wang X, et al. Oridonin induces apoptosis in esophageal squamous cell carcinoma by inhibiting cytoskeletal protein LASP1 and PDLIM1. Molecules. 2023;28(2):805.","journal-title":"Molecules"},{"key":"983_CR164","doi-asserted-by":"publisher","first-page":"5751","DOI":"10.2147\/OTT.S208924","volume":"12","author":"B Wang","year":"2019","unstructured":"Wang B, Shen C, Li Y, Zhang T, Huang H, Ren J. Oridonin overcomes the gemcitabine resistant PANC-1\/Gem cells by regulating GST pi and LRP\/1 ERK\/JNK signalling. Onco Targets Ther. 2019;12:5751\u201365.","journal-title":"Onco Targets Ther"},{"key":"983_CR165","doi-asserted-by":"publisher","first-page":"8081","DOI":"10.2147\/CMAR.S257482","volume":"12","author":"X Li","year":"2020","unstructured":"Li X, Chen W, Liu K, Zhang S, Yang R, Liu K, et al. Oridonin sensitizes hepatocellular carcinoma to the anticancer effect of sorafenib by targeting the Akt pathway. Cancer Manag Res. 2020;12:8081\u201391.","journal-title":"Cancer Manag Res"},{"key":"983_CR166","first-page":"601","volume":"20","author":"M Hashemzehi","year":"2021","unstructured":"Hashemzehi M, Yavari N, Rahmani F, Asgharzadeh F, Soleimani A, Shakour N, et al. EXCLI J. 2021;20:601\u201313.","journal-title":"EXCLI J"},{"issue":"1","key":"983_CR167","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s10120-017-0726-5","volume":"21","author":"H Saito","year":"2018","unstructured":"Saito H, Fushida S, Harada S, Miyashita T, Oyama K, Yamaguchi T. Importance of human peritoneal mesothelial cells in the progression, fibrosis, and control of gastric cancer: inhibition of growth and fibrosis by tranilast. Gastric Cancer. 2018;21(1):55\u201367.","journal-title":"Gastric Cancer"},{"issue":"2","key":"983_CR168","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/s00535-017-1338-x","volume":"53","author":"A Shiozaki","year":"2018","unstructured":"Shiozaki A, Kudou M, Ichikawa D, Fujiwara H, Shimizu H, Ishimoto T, et al. Esophageal cancer stem cells are suppressed by tranilast, a TRPV2 channel inhibitor. J Gastroenterol. 2018;53(2):197\u2013207.","journal-title":"J Gastroenterol"},{"issue":"1","key":"983_CR169","doi-asserted-by":"publisher","first-page":"4375","DOI":"10.1038\/s41467-019-12370-8","volume":"10","author":"N Ershaid","year":"2019","unstructured":"Ershaid N, Sharon Y, Doron H, Raz Y, Shani O, Cohen N, et al. NLRP3 inflammasome in fibroblasts links tissue damage with inflammation in breast cancer progression and metastasis. Nat Commun. 2019;10(1):4375.","journal-title":"Nat Commun"},{"issue":"9","key":"983_CR170","doi-asserted-by":"publisher","first-page":"2695","DOI":"10.1084\/jem.20160392","volume":"214","author":"B Weichand","year":"2017","unstructured":"Weichand B, Popp R, Dziumbla S, Mora J, Strack E, Elwakeel E, et al. S1PR1 on tumor-associated macrophages promotes lymphangiogenesis and metastasis via NLRP3\/IL-1\u03b2. Exp Med. 2017;214(9):2695\u2013713.","journal-title":"Exp Med"},{"issue":"7","key":"983_CR171","doi-asserted-by":"publisher","first-page":"BSR20200730","DOI":"10.1042\/BSR20200730","volume":"40","author":"Q Zheng","year":"2020","unstructured":"Zheng Q, Yao D, Cai Y, Zhou T. NLRP3 augmented resistance to gemcitabine in triple-negative breast cancer cells via EMT\/IL-1\u03b2\/Wnt\/\u03b2-catenin signaling pathway. Biosci Rep. 2020;40(7):BSR20200730.","journal-title":"Biosci Rep"},{"issue":"5","key":"983_CR172","doi-asserted-by":"publisher","first-page":"574","DOI":"10.3390\/ph15050574","volume":"15","author":"IW Tengesdal","year":"2022","unstructured":"Tengesdal IW, Li S, Powers NE, May M, Neff CP, Joosten LAB, et al. Activation of host-NLRP3 inflammasome in myeloid cells dictates response to anti-PD-1 therapy in metastatic breast cancers. Pharmaceuticals (Basel). 2022;15(5):574.","journal-title":"Pharmaceuticals (Basel)"},{"key":"983_CR173","doi-asserted-by":"publisher","DOI":"10.3389\/fbioe.2021.600579","volume":"9","author":"Y Zhao","year":"2021","unstructured":"Zhao Y, Xiao W, Peng W, Huang Q, Wu K, Evans CE, et al. Oridonin-loaded nanoparticles inhibit breast cancer progression through regulation of ROS-related Nrf2 signaling pathway. Front Bioeng Biotechnol. 2021;9: 600579.","journal-title":"Front Bioeng Biotechnol"},{"key":"983_CR174","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2021.111844","volume":"141","author":"S Osman","year":"2021","unstructured":"Osman S, Raza A, Al-Zaidan L, Inchakalody VP, Merhi M, Prabhu KS, et al. Anti-cancer effects of Tranilast: an update. Review Biomed Pharmacother. 2021;141: 111844.","journal-title":"Review Biomed Pharmacother"},{"issue":"3","key":"983_CR175","doi-asserted-by":"publisher","first-page":"288","DOI":"10.21037\/tlcr.2016.06.07","volume":"5","author":"C Zappa","year":"2016","unstructured":"Zappa C, Mousa SA. Non-small cell lung cancer: current treatment and future advances. Transl Lung Cancer Res. 2016;5(3):288\u2013300.","journal-title":"Transl Lung Cancer Res"},{"issue":"1","key":"983_CR176","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1186\/s13046-020-01688-7","volume":"39","author":"M Liang","year":"2020","unstructured":"Liang M, Chen X, Wang L, Qin L, Wang H, Sun Z, et al. Cancer-derived exosomal TRIM59 regulates macrophage NLRP3 inflammasome activation to promote lung cancer progression. J Exp Clin Cancer Res. 2020;39(1):176.","journal-title":"J Exp Clin Cancer Res"},{"issue":"6","key":"983_CR177","doi-asserted-by":"publisher","first-page":"3287","DOI":"10.21873\/anticanres.14311","volume":"40","author":"K Takahashi","year":"2020","unstructured":"Takahashi K, Menju T, Nishikawa S, Miyata R, Tanaka S, Yutaka Y, et al. Tranilast inhibits TGF-\u03b21-induced epithelial-mesenchymal transition and invasion\/metastasis via the suppression of Smad4 in human lung cancer cell lines. Anticancer Res. 2020;40(6):3287\u201396.","journal-title":"Anticancer Res"},{"issue":"8","key":"983_CR178","doi-asserted-by":"publisher","first-page":"2378","DOI":"10.3390\/ijms19082378","volume":"19","author":"H Park","year":"2018","unstructured":"Park H, Jeong YJ, Han N-K, Kim JS, Lee H-J. Oridonin enhances radiation-induced cell death by promoting DNA damage in non-small cell lung cancer cells. Int J Mol Sci. 2018;19(8):2378.","journal-title":"Int J Mol Sci"},{"issue":"4","key":"983_CR179","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1111\/j.1755-148X.2012.01008.x","volume":"25","author":"D Verma","year":"2012","unstructured":"Verma D, Bivik C, Farahani E, Synnerstad I, Fredrikson M, Enerb\u00e4ck C, et al. Inflammasome polymorphisms confer susceptibility to sporadic malignant melanoma. Pigment Cell Melanoma Res. 2012;25(4):506\u201313.","journal-title":"Pigment Cell Melanoma Res"},{"issue":"2","key":"983_CR180","doi-asserted-by":"publisher","first-page":"294","DOI":"10.3390\/cells12020294","volume":"12","author":"A Dinarello","year":"2023","unstructured":"Dinarello A, Mills TS, Tengesdal IW, Powers NE, Azam T, Dinarello CA. Dexamethasone and OLT1177 cooperate in the reduction of melanoma growth by inhibiting STAT3 functions. Cells. 2023;12(2):294.","journal-title":"Cells"},{"issue":"6","key":"983_CR181","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1111\/sji.12242","volume":"80","author":"Y Ohshio","year":"2014","unstructured":"Ohshio Y, Hanaoka J, Kontani K, Teramoto K. Tranilast inhibits the function of cancer-associated fibroblasts responsible for the induction of immune suppressor cell types. Scand J Immunol. 2014;80(6):408\u201316.","journal-title":"Scand J Immunol"},{"issue":"1","key":"983_CR182","doi-asserted-by":"publisher","first-page":"9","DOI":"10.20892\/j.issn.2095-3941.2016.0084","volume":"14","author":"BM Reid","year":"2017","unstructured":"Reid BM, Permuth JB, Sellers TA. Epidemiology of ovarian cancer: a review. Cancer Biol Med. 2017;14(1):9\u201332.","journal-title":"Cancer Biol Med"},{"issue":"3","key":"983_CR183","doi-asserted-by":"publisher","first-page":"3704","DOI":"10.18632\/oncotarget.23364","volume":"9","author":"C-M Chang","year":"2017","unstructured":"Chang C-M, Wang M-L, Lu K-H, Yang Y-P, Juang C-M, Wang P-H. Integrating the dysregulated inflammasome-based molecular functionome in the malignant transformation of endometriosis-associated ovarian carcinoma. Oncotarget. 2017;9(3):3704\u201326.","journal-title":"Oncotarget"},{"issue":"1","key":"983_CR184","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0227081","volume":"15","author":"J Luborsky","year":"2020","unstructured":"Luborsky J, Barua A, Edassery S, Bahr JM, Edassery SL. Inflammasome expression is higher in ovarian tumors than in normal ovary. PLoS ONE. 2020;15(1): e0227081.","journal-title":"PLoS ONE"},{"issue":"4","key":"983_CR185","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.5114\/aoms.2018.77068","volume":"15","author":"Y Wang","year":"2019","unstructured":"Wang Y, Zhu Z. Oridonin inhibits metastasis of human ovarian cancer cells by suppressing the mTOR pathway. Arch Med Sci. 2019;15(4):1017\u201327.","journal-title":"Arch Med Sci"},{"issue":"3","key":"983_CR186","doi-asserted-by":"publisher","first-page":"608","DOI":"10.3390\/cancers12030608","volume":"12","author":"M Mariniello","year":"2020","unstructured":"Mariniello M, Petruzzelli R, Wanderlingh LG, La Montagna R, Carissimo A, Pane F, et al. Synthetic lethality screening identifies FDA-approved drugs that overcome ATP7B-mediated tolerance of tumor cells to cisplatin. Cancers (Basel). 2020;12(3):608.","journal-title":"Cancers (Basel)"},{"issue":"3","key":"983_CR187","first-page":"973","volume":"53","author":"X-F Yin","year":"2018","unstructured":"Yin X-F, Zhang Q, Chen Z-Y, Wang H-F, Li X, Wang H-X, et al. NLRP3 in human glioma is correlated with increased WHO grade, and regulates cellular proliferation, apoptosis and metastasis via epithelial-mesenchymal transition and the PTEN\/AKT signaling pathway. Int J Oncol. 2018;53(3):973\u201386.","journal-title":"Int J Oncol"},{"issue":"5","key":"983_CR188","doi-asserted-by":"publisher","first-page":"557","DOI":"10.3727\/096504018X15264647024196","volume":"27","author":"L Xue","year":"2019","unstructured":"Xue L, Lu B, Gao B, Shi Y, Xu J, Yang R, et al. NLRP3 promotes glioma cell proliferation and invasion via the interleukin-1\u03b2\/NF-\u03baB p65 signals. Oncol Res. 2019;27(5):557\u201364.","journal-title":"Oncol Res"},{"issue":"8","key":"983_CR189","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.1016\/j.immuni.2021.07.002","volume":"54","author":"D Hofbauer","year":"2021","unstructured":"Hofbauer D, Mougiakakos D, Broggini L, Zaiss M, B\u00fcttner-Herold M, Bach C, et al. \u03b22-microglobulin triggers NLRP3 inflammasome activation in tumor-associated macrophages to promote multiple myeloma progression. Immunity. 2021;54(8):1772-1787.e9.","journal-title":"Immunity"},{"issue":"1","key":"983_CR190","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1038\/s41467-020-15497-1","volume":"11","author":"S Hamarsheh","year":"2020","unstructured":"Hamarsheh S, Osswald L, Saller BS, Unger S, De Feo D, Vinnakota JM, et al. Oncogenic KrasG12D causes myeloproliferation via NLRP3 inflammasome activation. Nat Commun. 2020;11(1):1659.","journal-title":"Nat Commun"},{"issue":"65","key":"983_CR191","doi-asserted-by":"publisher","first-page":"108571","DOI":"10.18632\/oncotarget.21010","volume":"8","author":"X Zhao","year":"2017","unstructured":"Zhao X, Zhang C, Hua M, Wang R, Zhong C, Yu J, et al. NLRP3 inflammasome activation plays a carcinogenic role through effector cytokine IL-18 in lymphoma. Oncotarget. 2017;8(65):108571\u201383.","journal-title":"Oncotarget"},{"key":"983_CR192","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.ejmech.2016.06.015","volume":"122","author":"Y Ding","year":"2016","unstructured":"Ding Y, Ding C, Ye N, Liu Z, Wold EA, Chen H, et al. Discovery and development of natural product oridonin-inspired anticancer agents. Eur J Med Chem. 2016;122:102\u201317.","journal-title":"Eur J Med Chem"},{"issue":"2","key":"983_CR193","doi-asserted-by":"publisher","first-page":"734","DOI":"10.3892\/ijo.2015.3294","volume":"48","author":"M Shi","year":"2016","unstructured":"Shi M, Ren X, Wang X, Wang H, Liu G, Yuan X, et al. A novel combination of oridonin and valproic acid in enhancement of apoptosis induction of HL-60 leukemia cells. Int J Oncol. 2016;48(2):734\u201346.","journal-title":"Int J Oncol"},{"issue":"3","key":"983_CR194","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1016\/j.sjbs.2017.01.042","volume":"24","author":"Y Zhang","year":"2017","unstructured":"Zhang Y, Wang L, Zi Y, Zhang L, Guo Y, Huang Y. Oridonin effectively reverses the drug resistance of cisplatin involving induction of cell apoptosis and inhibition of MMP expression in human acute myeloid leukemia cells. Saudi J Biol Sci. 2017;24(3):678\u201386.","journal-title":"Saudi J Biol Sci"},{"issue":"1","key":"983_CR195","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1186\/s13046-017-0589-y","volume":"36","author":"C-F Huang","year":"2017","unstructured":"Huang C-F, Chen L, Li Y-C, Wu L, Yu G-T, Zhang W-F. NLRP3 inflammasome activation promotes inflammation-induced carcinogenesis in head and neck squamous cell carcinoma. J Exp Clin Cancer Res. 2017;36(1):116.","journal-title":"J Exp Clin Cancer Res"},{"issue":"30","key":"983_CR196","doi-asserted-by":"publisher","first-page":"48972","DOI":"10.18632\/oncotarget.16903","volume":"8","author":"JY Bae","year":"2017","unstructured":"Bae JY, Lee S-W, Shin Y-H, Lee J-H, Jahng JW, Park K. P2X7 receptor and NLRP3 inflammasome activation in head and neck cancer. Oncotarget. 2017;8(30):48972\u201382.","journal-title":"Oncotarget"},{"issue":"1","key":"983_CR197","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1007\/s43440-021-00324-1","volume":"74","author":"L Kazantseva","year":"2022","unstructured":"Kazantseva L, Becerra J, Santos-Ruiz L. Oridonin enhances antitumor effects of doxorubicin in human osteosarcoma cells. Pharmacol Rep. 2022;74(1):248\u201356.","journal-title":"Pharmacol Rep"},{"issue":"Suppl 2","key":"983_CR198","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1002\/ijgo.12612","volume":"143","author":"F Amant","year":"2018","unstructured":"Amant F, Mirza MR, Koskas M, Creutzberg CL. Cancer of the corpus uteri. Int J Gynaecol Obstet. 2018;143(Suppl 2):37\u201350.","journal-title":"Int J Gynaecol Obstet"},{"key":"983_CR199","doi-asserted-by":"publisher","first-page":"6927","DOI":"10.2147\/OTT.S218240","volume":"12","author":"S-G Liu","year":"2019","unstructured":"Liu S-G, Wu X-X, Hua T, Xin X-Y, Feng D-L, Chi S-Q, et al. Onco Targets Ther. 2019;12:6927\u201336.","journal-title":"Onco Targets Ther"},{"issue":"1","key":"983_CR200","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s12885-019-6491-6","volume":"20","author":"Y Yang","year":"2020","unstructured":"Yang Y, Liu PY, Bao W, Chen SJ, Wu FS, Zhu PY. Hydrogen inhibits endometrial cancer growth via a ROS\/NLRP3\/caspase-1\/GSDMD-mediated pyroptotic pathway. BMC Cancer. 2020;20(1):28.","journal-title":"BMC Cancer"},{"issue":"1","key":"983_CR201","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/s13046-021-01878-x","volume":"40","author":"W Huang","year":"2021","unstructured":"Huang W, Zhang L, Yang M, Wu X, Wang X, Huang W, et al. Cancer-associated fibroblasts promote the survival of irradiated nasopharyngeal carcinoma cells via the NF-\u03baB pathway. J Exp Clin Cancer Res. 2021;40(1):87.","journal-title":"J Exp Clin Cancer Res"},{"issue":"1","key":"983_CR202","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/s41420-021-00766-9","volume":"7","author":"Z Xu","year":"2021","unstructured":"Xu Z, Wang H, Qin Z, Zhao F, Zhou L, Xu L, et al. NLRP3 inflammasome promoted the malignant progression of prostate cancer via the activation of caspase-1. Cell Death Discov. 2021;7(1):399.","journal-title":"Cell Death Discov"},{"issue":"4","key":"983_CR203","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/s41568-019-0123-y","volume":"19","author":"R Karki","year":"2019","unstructured":"Karki R, Kanneganti T-D. Diverging inflammasome signals in tumorigenesis and potential targeting. Review Nat Rev Cancer. 2019;19(4):197\u2013214.","journal-title":"Review Nat Rev Cancer"},{"key":"983_CR204","doi-asserted-by":"publisher","first-page":"39075","DOI":"10.1038\/srep39075","volume":"6","author":"S Itani","year":"2016","unstructured":"Itani S, Watanabe T, Nadatani Y, Sugimura N, Shimada S, Takeda S, et al. NLRP3 inflammasome has a protective effect against oxazolone-induced colitis: a possible role in ulcerative colitis. Sci Rep. 2016;6:39075.","journal-title":"Sci Rep"},{"key":"983_CR205","doi-asserted-by":"publisher","first-page":"10257","DOI":"10.2147\/CMAR.S226356","volume":"11","author":"S Nie","year":"2019","unstructured":"Nie S, Wang X, Wang H. NLRP3 inflammasome mediated interleukin-1\u03b2 production in cancer-associated fibroblast contributes to ALA-PDT for cutaneous squamous cell carcinoma. Cancer Manag Res. 2019;11:10257\u201367.","journal-title":"Cancer Manag Res"},{"issue":"23","key":"983_CR206","doi-asserted-by":"publisher","first-page":"5759","DOI":"10.1016\/j.cell.2021.09.032","volume":"184","author":"C Shen","year":"2021","unstructured":"Shen C, Li R, Negro R, Cheng J, Vora SM, Fu T-M, et al. Phase separation drives RNA virus-induced activation of the NLRP6 inflammasome. Cell. 2021;184(23):5759-5774.e20.","journal-title":"Cell"}],"container-title":["Journal of Biomedical Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12929-023-00983-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12929-023-00983-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12929-023-00983-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,27]],"date-time":"2023-10-27T13:07:28Z","timestamp":1698412048000},"score":1,"resource":{"primary":{"URL":"https:\/\/jbiomedsci.biomedcentral.com\/articles\/10.1186\/s12929-023-00983-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,27]]},"references-count":206,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["983"],"URL":"https:\/\/doi.org\/10.1186\/s12929-023-00983-7","relation":{},"ISSN":["1423-0127"],"issn-type":[{"value":"1423-0127","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,27]]},"assertion":[{"value":"30 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"90"}}